Concord Medical unit issues HK$68M 2% bonds

Concord Medical Services Holdings Limited reported that its subsidiary, Concord Healthcare Group Co., Ltd., completed an issue of 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million.

Accepted by SEC EDGAR 05/13/2026 - 04:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Concord Medical Services Holdings Limited reported that its subsidiary, Concord Healthcare Group Co., Ltd., completed an issue of 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million. The transaction was completed on May 13, 2026 under a placing and subscription agreement dated May 10, 2026.

Haitong International Securities Company Limited acted as placing agent and Dragon Merit Holdings Limited was the subscriber. Concord Healthcare is listed on the Main Board of the Hong Kong Stock Exchange, and its annual report information is available on the HKSE website.

Key Figures

Convertible bond principal: HK$68 million Coupon rate: 2% Maturity year: 2027 +2 more

5 metrics

Convertible bond principal HK$68 million Aggregate principal amount of 2% convertible bonds due 2027

Coupon rate 2% Interest rate on Concord Healthcare convertible bonds

Maturity year 2027 Maturity of the 2% convertible bonds

Completion date May 13, 2026 Date the bond issue was completed

Agreement date May 10, 2026 Date of placing and subscription agreement

Key Terms

convertible bonds, placing and subscription agreement, foreign private issuer, Main Board of The Stock Exchange of Hong Kong Limited

4 terms

convertible bonds financial

"completed the issue of 2% convertible bonds due 2027 in the aggregate principal amount of HK$68 million"

A convertible bond is a loan a company issues that pays regular interest and can be exchanged for a fixed number of the company’s shares under specified terms. It matters to investors because it combines the steady income and lower downside risk of a bond with the upside potential of owning stock—like holding a ticket that can be cashed for equity if the share price rises—affecting returns, risk, and shareholder dilution.

placing and subscription agreement financial

"in accordance with the placing and subscription agreement dated May 10, 2026"

foreign private issuer regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Main Board of The Stock Exchange of Hong Kong Limited regulatory

"a company listed on the Main Board of The Stock Exchange of Hong Kong Limited"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What financing transaction did Concord Medical (CCM) disclose in this 6-K?

Concord Medical disclosed that its subsidiary Concord Healthcare issued 2% convertible bonds due 2027 with an aggregate principal amount of HK$68 million. The bonds were issued under a placing and subscription agreement completed on May 13, 2026.

What are the key terms of Concord Healthcare’s new convertible bonds?

The bonds carry a 2% interest rate and mature in 2027, with an aggregate principal amount of HK$68 million. They were placed pursuant to a May 10, 2026 agreement with Haitong International Securities Company Limited.

Who participated in Concord Healthcare’s HK$68 million bond issue?

Haitong International Securities Company Limited served as the placing agent, and Dragon Merit Holdings Limited acted as the subscriber. These parties participated under a placing and subscription agreement dated May 10, 2026 for the 2% convertible bonds.

When was Concord Healthcare’s 2% convertible bond issue completed?

The issue of Concord Healthcare’s 2% convertible bonds due 2027 was completed on May 13, 2026. This completion followed a placing and subscription agreement entered into on May 10, 2026 with the placing agent and subscriber.

Where can investors find Concord Healthcare’s HKSE annual report information?

Annual report information for Concord Healthcare, listed on the Main Board of the Hong Kong Stock Exchange under stock code 2453.HK, is accessible through the HKSE’s website at www.hkexnews.hk. The company’s H share listing was previously announced on January 9, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER 

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER 

THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-34563

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Room A1-A5 26/F, East Zone, Hanwei Plaza 

No. 7 Guanghua Road, Chaoyang District, 

Beijing 100020 

People’s Republic of China 

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x     Form 40-F ¨

Concord Healthcare Completed the Issue of Convertible Bonds

Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM) and a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, completed the issue of 2% convertible bonds due 2027 in the aggregate principal amount of HK$68 million on May 13, 2026, in accordance with the placing and subscription agreement dated May 10, 2026 with Haitong International Securities Company Limited as the placing agent and Dragon Merit Holdings Limited as the subscriber.

The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s annual report on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CONCORD MEDICAL SERVICES HOLDINGS LIMITED
	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

Date: May 13, 2026